Theravance Biopharma, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 222 | 0.0% | 11,876 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 174 | 0.0% | 15,747 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 132 | 0.0% | 14,727 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 145 | 0.0% | 15,432 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 126 | 0.0% | 15,611 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 141 | 0.0% | 16,623 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 171 | 0.0% | 19,054 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 219 | 0.0% | 19,504 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 205 | 0.0% | 23,798 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 246 | 0.0% | 23,798 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 262 | 0.0% | 24,154 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 271 | 0.0% | 24,154 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 249 | 0.0% | 24,540 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 226 | 0.0% | 24,987 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 232 | 0.0% | 24,263 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 345 | 0.0% | 31,233 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 251 | 0.0% | 33,873 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 433 | 0.0% | 29,791 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 531 | 0.0% | 26,036 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 490 | 0.0% | 27,569 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 386 | 0.0% | 26,133 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 551 | 0.0% | 26,701 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 671 | 0.0% | 29,028 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 709 | 0.0% | 25,634 | 12/31/2019 |